Devices industry more hopeful of escaping pharma review
This article was originally published in Clinica
Executive Summary
The EU medical devices industry is optimistic that the most recent amendments to the European Commission proposal on the review of EU pharmaceutical legislation is more favourable to the medical devices industry than earlier versions and proposed amendments to the text.